Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-25-073180
Filing Date
2025-08-01
Accepted
2025-08-01 17:23:35
Documents
13
Period of Report
2025-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2522037d3_8ka.htm   iXBRL 8-K/A 28395
2 EXHIBIT 10.1 tm2522037d3_ex10-1.htm EX-10.1 1755812
  Complete submission text file 0001104659-25-073180.txt   2318053

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnk-20250731.xsd EX-101.SCH 3023
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20250731_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20250731_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2522037d3_8ka_htm.xml XML 4270
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: 8-K/A | Act: 34 | File No.: 001-35803 | Film No.: 251177199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)